Literature DB >> 11696703

Renal outcome 25 years after donor nephrectomy.

D A Goldfarb1, S F Matin, W E Braun, M J Schreiber, B Mastroianni, D Papajcik, H A Rolin, S Flechner, M Goormastic, A C Novick.   

Abstract

PURPOSE: The extended outcome after kidney donation has been a particular concern ever since the recognition of hyperfiltration injury. Few published reports have examined donor renal outcome after 20 years or greater. Kidney transplantation has been performed at the Cleveland Clinic Foundation since 1963, at which there is extensive experience with live donor transplantation. We assess the impact of donor nephrectomy on renal function, urinary protein excretion and development of hypertension postoperatively to examine whether renal deterioration occurs with followup after 20 years or greater.
MATERIALS AND METHODS: From 1963 to 1975, 180 live donor nephrectomies were performed at the Cleveland Clinic. We attempted to contact all patients to request participation in our study. Those 70 patients who agreed to participate in the study were mailed a package containing a 24-hour urine container (for assessment of creatinine, and total protein and albumin), a vial for blood collection (for assessment of serum creatinine) and a medical questionnaire. All specimens were returned to and processed by the Cleveland Clinic medical laboratories. Blood pressure was taken and recorded by a local physician. A 24-hour creatinine clearance and the Cockcroft-Gault formula were used to estimate renal function, and values were compared with an age adjusted glomerular filtration rate for a solitary kidney.
RESULTS: Mean patient followup was 25 years. The 24-hour urinary creatinine clearance decreased to 72% of the value before donation. For the entire study cohort serum creatinine and systolic blood pressure after donation were significantly increased compared with values before, although still in the normal range. The overall incidence of hypertension was comparable to that expected in the age matched general population. There was no gender or age difference (younger or older than 50 years) for 24-hour urinary creatinine clearance, or change in serum creatinine before or after donation. Urinary protein and albumin excretion after donation was significantly higher in males compared with females. There were 13 (19%) subjects who had a 24-hour urinary protein excretion that was greater than 0.15 gm./24 hours, 5 (7%) of whom had greater than 0.8. No gender difference was noted in blood pressure, and there were no significant changes in diastolic pressure based on gender or age.
CONCLUSIONS: Overall, renal function is well preserved with a mean followup of 25 years after donor nephrectomy. Males had significantly higher protein and albumin excretion than females but no other clinically significant differences in renal function, blood pressure or proteinuria were noted between them or at age of donation. Proteinuria increases with marginal significance but appears to be of no clinical consequence in most patients. Patients with mild or borderline proteinuria before donation may represent a subgroup at particular risk for the development of significant proteinuria 20 years or greater after donation. The overall incidence of proteinuria in our study is in the range of previously reported values after donor nephrectomy.

Entities:  

Mesh:

Year:  2001        PMID: 11696703

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  43 in total

1.  Changes in glomerular filtration rate after donation in living kidney donors: a single-center cohort study.

Authors:  Takako Saito; Keiko Uchida; Hideki Ishida; Kazunari Tanabe; Kosaku Nitta
Journal:  Int Urol Nephrol       Date:  2014-11-01       Impact factor: 2.370

2.  Very low but stable glomerular filtration rate after living kidney donation: is the concept of "chronic kidney disease" applicable to kidney donors?

Authors:  Ryo Kido; Yugo Shibagaki; Kazuhiro Iwadoh; Ichiro Nakajima; Shohei Fuchinoue; Toshiro Fujita; Satoshi Teraoka
Journal:  Clin Exp Nephrol       Date:  2010-03-26       Impact factor: 2.801

3.  Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study.

Authors:  William C Huang; Andrew S Levey; Angel M Serio; Mark Snyder; Andrew J Vickers; Ganesh V Raj; Peter T Scardino; Paul Russo
Journal:  Lancet Oncol       Date:  2006-09       Impact factor: 41.316

Review 4.  Low Birth Weight, Blood Pressure and Renal Susceptibility.

Authors:  Laura E Coats; Gwendolyn K Davis; Ashley D Newsome; Norma B Ojeda; Barbara T Alexander
Journal:  Curr Hypertens Rep       Date:  2019-06-21       Impact factor: 5.369

5.  Assessment of long-term cardiovascular effects of unilateral nephrectomy.

Authors:  Sultan Ozkurt; Yusuf Karavelioglu; Macit Kalcik; Ahmet Musmul
Journal:  Int Urol Nephrol       Date:  2017-03-04       Impact factor: 2.370

Review 6.  Pathogenesis of essential hypertension: historical paradigms and modern insights.

Authors:  Richard J Johnson; Dan I Feig; Takahiko Nakagawa; L Gabriela Sanchez-Lozada; Bernardo Rodriguez-Iturbe
Journal:  J Hypertens       Date:  2008-03       Impact factor: 4.844

7.  Change in renal parenchymal volume in living kidney transplant donors.

Authors:  Turun Song; Lei Fu; Zixing Huang; Shaofeng He; Ruining Zhao; Tao Lin; Qiang Wei
Journal:  Int Urol Nephrol       Date:  2013-11-01       Impact factor: 2.370

8.  The National Landscape of Living Kidney Donor Follow-Up in the United States.

Authors:  M L Henderson; A G Thomas; A Shaffer; A B Massie; X Luo; C M Holscher; T S Purnell; K L Lentine; D L Segev
Journal:  Am J Transplant       Date:  2017-06-30       Impact factor: 8.086

Review 9.  Oncological and renal medical importance of kidney-sparing surgery.

Authors:  Paul Russo
Journal:  Nat Rev Urol       Date:  2013-03-05       Impact factor: 14.432

10.  Long-term renal function and cardiovascular disease risk in obese kidney donors.

Authors:  Mohammad M Tavakol; Flavio G Vincenti; Hamid Assadi; Michael J Frederick; Stephen J Tomlanovich; John P Roberts; Andrew M Posselt
Journal:  Clin J Am Soc Nephrol       Date:  2009-05-14       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.